Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business
Anesiva, Inc. - Financial and Strategic Analysis Review

Anesiva, Inc. - Financial and Strategic Analysis Review - companiesandmarkets.com adds new report


Print article Print article
Refer this article Refer to a friend
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2009-04-22 10:33:01 - Anesiva, Inc. - Financial and Strategic Analysis Review - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/Anesiva,-Inc ..

Anesiva, Inc. - Financial and Strategic Analysis Review

Summary

Anesiva, Inc. (Anesiva) is engaged in development and commercialization of novel medicines for pain management. It is a biopharmaceutical company focusing on research and development of therapies for the treatment of post surgical pain, musculoskeletal pain, post-trauma neuropathic pain and intravenous line placements. The company is in development stage with no commercialized products.

It generates revenue from out licensing of its technology. It is developing two products namely Zingo and Adlea which are in clinical trial stage. The company is headquartered at South San Francisco in California, United States and employs about 100 people.

This report presents an in-depth business, strategic and financial analysis of Anesiva, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and views on the company.

Scope

-The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.

-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.

-The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.

-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.

-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

-A quick “one-stop-shop” to understand the company.

-Enhance business/sales activities by understanding customers’ businesses better.

-Get detailed information and financial & strategic analysis on companies operating in your industry.

-Identify prospective partners and suppliers – with key data on their businesses and locations.

-Capitalize on competitors’ weaknesses and target the market opportunities available to them.

-Compare your company’s financial trends with those of your peers / competitors.

-Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Terms & Conditions | Privacy | About us | Contact PR-inside.com